INC Research to Present at Upcoming Investor Conferences

RALEIGH, N.C., Sept. 2, 2015 (GLOBE NEWSWIRE) — INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced it will participate in two upcoming investor conferences. Presenting at the conferences will be Jamie Macdonald, Chief Executive Officer, and Greg Rush, Chief Financial Officer.

Mr. Macdonald is scheduled to present at the Robert W. Baird 2015 Healthcare Conference in New York on Wednesday, Sept. 9 at 2:35 PM EDT.

Mr. Rush is scheduled to present at the Morgan Stanley Global Healthcare Conference in New York on Friday, Sept. 18 at 2:45 PM EDT.

Links to INC Research’s live presentations and archived audio replays, if applicable, will be available via the Company’s Investor Relations website at investor.incresearch.com.

About INC Research

INC Research (Nasdaq:INCR) is a leading global contract research organization (CRO) providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was ranked “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, N.C., with operations across six continents and experience spanning more than 100 countries. 

CONTACT: Investor Relations Contact:
         Ronnie Speight
         Vice President, Investor Relations
         Phone: +1 (919) 745-2745
         Email: Investor.Relations@incresearch.com
         
         Press/Media Contact:
         Lori Dorer
         Senior Director, Corporate Communications
         Phone: +1 (513) 345-1685
         Email: Corporate.Communications@incresearch.com

Share this post